In its late-stage licensing deal with GW Pharmaceuticals for Sativex, Bayer accepted UK-only rights, and will share the product's value equally with GW. This unusual agreement largely reflects the par
Acquisitions Cell Therapeutics to acquire Novuspharma Cell Therapeutics Inc. (Seattle, WA) Novuspharma SPA (Bresso, Italy) Cancer therapeutics companies CTI BioPharma Corp. and Novuspharma SA ha